Clinical Trials Arena on MSN

CERo commences second cohort of AML trial

The open-label, first-in-human Phase I/Ib study is evaluating CER-1236's preliminary safety and efficacy in participants.
PCOS remains a highly prevalent disorder in need of further exploration for its role in long-term health outcomes.
Often confused for a common cold, respiratory syncytial virus (RSV) can in fact be serious and should be studied more closely ...
Increased risk of DENV-infection (primarily DENV3) was observed up to 300 days post-SARS-CoV-2 infection (predominantly ...
Children and young people have higher risks of rare vascular and inflammatory diseases up to 12 months after a first COVID-19 ...
A retrospective analysis of a large cohort of patients with diabetic macular edema showed high prevalence of bilateral ...
An estimated 50% of patients with SLE will develop lupus nephritis in their lifetime, with people of African descent more ...
Estrella Immunopharma, Inc. (NASDAQ: ESLA) ("Estrella" or the "Company"), a clinical stage biopharmaceutical company ...
Background Statistical shape atlases have been used in large-cohort studies to investigate relationships between heart shape ...